Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Pharma & Healthcare

>>

Global Eculizumab Sales Market


Global Eculizumab Sales Market Report 2020 by Manufacturer, Region, Type and Application

Report code: SDMRPH1249301 | Industry: Pharma & Healthcare  | Published On: Jun. 2020


According to XYZResearch's analysis, in the last several years, Global market of Eculizumab developed rapidly, with an average growth rate of 34%. In 2016, Global Revenue of Eculizumab was nearly 2850 M USD; the actual production was about 460 thousand units.

Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.

The classification of Eculizumab includes Plasma Exchange and Plasma Infusion, and the proportion of Plasma Exchange in 2016 was about 72%, and the proportion was in increasing trend from 2012 to 2016.

Eculizumab is widely used for patients of PNH, aHUS and others. The most proportion of Eculizumab was used for patients of aHUS, and the proportion in 2016 was about 55%.

North America was the largest consumption place, with a consumption market share nearly 40.3% in 2016. Following North America, Europe was the second largest consumption place with the consumption market share of 32.6%.

Alexion is the major player in global Eculizumab market. Soliris (eculizumab) is the first and only therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH), a lifethreatening and ultra-rare genetic blood disorder, or atypical hemolytic uremic syndrome (aHUS), a life-threatening and ultra-rare genetic disease. PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Eculizumab for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

Global Eculizumab market competition by top manufacturers/players, with Eculizumab sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Alexion
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Plasma Exchange
Plasma Infusion
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Eculizumab for each application, including
PNH
aHUS
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table  of  Contents

1  Executive  Summary
        1.1  Definition  and  Specification
        1.2  Report  Overview
                1.2.1  Manufacturers  Overview
                1.2.2  Regions  Overview
                1.2.3  Type  Overview
                1.2.4  Application  Overview
        1.3  Industrial  Chain
                1.3.1  Eculizumab  Overall  Industrial  Chain
                1.3.2  Upstream
                1.3.3  Downstream
        1.4  Industry  Situation
                1.4.1  Industrial  Policy
                1.4.2  Product  Preference
                1.4.3  Economic/Political  Environment
        1.5  SWOT  Analysis
2  Market  Analysis  by  Types
        2.1  Overall  Market  Performance(Volume)
                  2.1.1  Plasma  Exchange
                  2.1.2  Plasma  Infusion
        2.2  Overall  Market  Performance(Value)
                  2.2.1  Plasma  Exchange
                  2.2.2  Plasma  Infusion
3  Product  Application  Market
        3.1  Overall  Market  Performance  (Volume)
                  3.1.1  PNH
                  3.1.2  aHUS
                  3.1.3  Other
4  Manufacturers  Profiles/Analysis
        4.1  Alexion
                4.1.1  Alexion  Profiles
                4.1.2  Alexion  Product  Information
                4.1.3  Alexion  Eculizumab  Sales,  Sales  Value(Million  USD),  Price  and  Gross  Profit
                4.1.4  Alexion  SWOT  Analysis
5  Market  Performance  for  Manufacturers
        5.1  Global  Eculizumab  Sales  (K  Units)  and  Market  Share  by  Manufacturers  2014-2020
        5.2  Global  Eculizumab  Revenue  (M  USD)  and  Market  Share  by  Manufacturers  2014-2020
        5.3  Global  Eculizumab  Price  (USD/Unit)  of  Manufacturers  2014-2020
        5.4  Global  Eculizumab  Gross  Margin  of  Manufacturers  2014-2020
        5.5  Market  Concentration
6  Regions  Market  Performance  for  Manufacturers
        6.1  China  Market  Performance  for  Manufacturers
                6.1.1  China  Eculizumab  Sales  (K  Units)  and  Share  of  Manufacturers  2014-2020
                6.1.2  China  Eculizumab  Revenue  (M  USD)  and  Share  of  Manufacturers  2014-2020
                6.1.3  China  Eculizumab  Price  (USD/Unit)  of  Manufacturers  2014-2020
                6.1.4  China  Eculizumab  Gross  Margin  of  Manufacturers  2014-2020
                6.1.5  Market  Concentration
        6.2  USA  Market  Performance  for  Manufacturers
                6.2.1  USA  Eculizumab  Sales  (K  Units)  and  Share  of  Manufacturers  2014-2020
                6.2.2  USA  Eculizumab  Revenue  (M  USD)  and  Share  of  Manufacturers  2014-2020
                6.2.3  USA  Eculizumab  Price  (USD/Unit)  of  Manufacturers  2014-2020
                6.2.4  USA  Eculizumab  Gross  Margin  of  Manufacturers  2014-2020
                6.2.5  Market  Concentration
        6.3  Europe  Market  Performance  for  Manufacturers
                6.3.1  Europe  Eculizumab  Sales  (K  Units)  and  Share  of  Manufacturers  2014-2020
                6.3.2  Europe  Eculizumab  Revenue  (M  USD)  and  Share  of  Manufacturers  2014-2020
                6.3.3  Europe  Eculizumab  Price  (USD/Unit)  of  Manufacturers  2014-2020
                6.3.4  Europe  Eculizumab  Gross  Margin  of  Manufacturers  2014-2020
                6.3.5  Market  Concentration
        6.4  Japan  Market  Performance  for  Manufacturers
                6.4.1  Japan  Eculizumab  Sales  (K  Units)  and  Share  of  Manufacturers  2014-2020
                6.4.2  Japan  Eculizumab  Revenue  (M  USD)  and  Share  of  Manufacturers  2014-2020
                6.4.3  Japan  Eculizumab  Price  (USD/Unit)  of  Manufacturers  2014-2020
                6.4.4  Japan  Eculizumab  Gross  Margin  of  Manufacturers  2014-2020
                6.4.5  Market  Concentration
        6.5  Korea  Market  Performance  for  Manufacturers
                6.5.1  Korea  Eculizumab  Sales  (K  Units)  and  Share  of  Manufacturers  2014-2020
                6.5.2  Korea  Eculizumab  Revenue  (M  USD)  and  Share  of  Manufacturers  2014-2020
                6.5.3  Korea  Eculizumab  Price  (USD/Unit)  of  Manufacturers  2014-2020
                6.5.4  Korea  Eculizumab  Gross  Margin  of  Manufacturers  2014-2020
                6.5.5  Market  Concentration
        6.6  India  Market  Performance  for  Manufacturers
                6.6.1  India  Eculizumab  Sales  (K  Units)  and  Share  of  Manufacturers  2014-2020
                6.6.2  India  Eculizumab  Revenue  (M  USD)  and  Share  of  Manufacturers  2014-2020
                6.6.3  India  Eculizumab  Price  (USD/Unit)  of  Manufacturers  2014-2020
                6.6.4  India  Eculizumab  Gross  Margin  of  Manufacturers  2014-2020
                6.6.5  Market  Concentration
        6.7  Southeast  Asia  Market  Performance  for  Manufacturers
                6.7.1  Southeast  Asia  Eculizumab  Sales  (K  Units)  and  Share  of  Manufacturers  2014-2020
                6.7.2  Southeast  Asia  Eculizumab  Revenue  (M  USD)  and  Share  of  Manufacturers  2014-2020
                6.7.3  Southeast  Asia  Eculizumab  Price  (USD/Unit)  of  Manufacturers  2014-2020
                6.7.4  Southeast  Asia  Eculizumab  Gross  Margin  of  Manufacturers  2014-2020
                6.7.5  Market  Concentration
        6.8  South  America  Market  Performance  for  Manufacturers
                6.8.1  South  America  Eculizumab  Sales  (K  Units)  and  Share  of  Manufacturers  2014-2020
                6.8.2  South  America  Eculizumab  Revenue  (M  USD)  and  Share  of  Manufacturers  2014-2020
                6.8.3  South  America  Eculizumab  Price  (USD/Unit)  of  Manufacturers  2014-2020
                6.8.4  South  America  Eculizumab  Gross  Margin  of  Manufacturers  2014-2020
                6.8.5  Market  Concentration
7  Global    Eculizumab  Market  Assessment  by  Regions  (2014-2020)
        7.1  Global  Eculizumab  Sales  (K  Units)  and  Market  Share  by  Regions  2014-2020
        7.2  Global  Eculizumab  Revenue  (M  USD)  and  Market  Share  by  Regions  2014-2020
        7.3  Global  Eculizumab  Price  (USD/Unit)  by  Regions  2014-2020
        7.4  Global  Eculizumab  Gross  Margin  by  Regions  2014-2020
8  Development  Trend  for  Regions
        8.1  Global  Eculizumab  Sales  and  Growth,  Sales  Value  and  Growth  Rate  2014-2020
        8.2  China  Eculizumab  Sales  and  Growth,  Sales  Value  and  Growth  Rate  2014-2020
        8.3  USA  Eculizumab  Sales  and  Growth,  Sales  Value  and  Growth  Rate2014-2020
        8.4  Europe  Eculizumab  Sales  and  Growth,  Sales  Value  and  Growth  Rate  2014-2020
        8.5  Japan  Eculizumab  Sales  and  Growth,  Sales  Value  and  Growth  Rate  2014-2020
        8.6  Korea  Eculizumab  Sales  and  Growth,  Sales  Value  and  Growth  Rate  2014-2020
        8.7  India  Eculizumab  Sales  and  Growth,  Sales  Value  and  Growth  Rate  2014-2020
        8.8  Southeast  Asia  Eculizumab  Sales  and  Growth,  Sales  Value  and  Growth  Rate  2014-2020
        8.8  Southeast  Asia  Eculizumab  Sales  and  Growth,  Sales  Value  and  Growth  Rate  2014-2020
9  Upstream  Source,  Technology  and  Cost
        9.1  Upstream  Source
        9.2  Technology
        9.3  Cost
10  Channel  Analysis
        10.1  Market  Channel
        10.2  Manufacturing  Plants  Distribution
11  Consumer  Analysis
        11.1  PNH  Industry
        11.2  aHUS  Industry
        11.3  Other  Industry
12  Market  Forecast  2021-2026
        12.1  Sales  (K  Units),  Revenue  (M  USD),  Market  Share  and  Growth  Rate  2021-2026
                12.1.1  Global  Eculizumab  Sales  (K  Units),  Revenue  (M  USD)  and  Market  Share  by  Regions  2021-2026
                12.1.2  Global  Eculizumab  Sales  (K  Units)  and  Growth  Rate  2021-2026
                12.1.3  China  Eculizumab  Sales  (K  Units),  Revenue  (M  USD)  and  Growth  Rate  2021-2026
                12.1.4  USA  Eculizumab  Sales  (K  Units),  Revenue  (M  USD)  and  Growth  Rate  2021-2026
                12.1.5  Europe  Eculizumab  Sales  (K  Units),  Revenue  (M  USD)  and  Growth  Rate  2021-2026
                12.1.6  Japan  Eculizumab  Sales  (K  Units),  Revenue  (M  USD)  and  Growth  Rate  2021-2026
                12.1.7  Korea  Eculizumab  Sales  (K  Units),  Revenue  (M  USD)  and  Growth  Rate  2021-2026
                12.1.8  India  Eculizumab  Sales  (K  Units),  Revenue  (M  USD)  and  Growth  Rate  2021-2026
                12.1.9  Southeast  Asia  Eculizumab  Sales  (K  Units),  Revenue  (M  USD)  and  Growth  Rate  2021-2026
                12.1.10  South  America  Eculizumab  Sales  (K  Units),  Revenue  (M  USD)  and  Growth  Rate  2021-2026
        12.2  Sales  (K  Units),  Revenue  (M  USD)  Forecast  by  Types  2021-2026
                12.2.1  Overall  Market  Performance
                12.2.2  Plasma  Exchange
                12.2.3  Plasma  Infusion
        12.3  Sales    (K  Units)  Forecast  by  Application  2021-2026
                12.3.1  Overall  Market  Performance
                12.3.2  PNH
                12.3.3  aHUS
                12.3.4  Other
        12.4  Price  (USD/Unit)  and  Gross  Profit
                12.4.1  Global  Eculizumab  Price  (USD/Unit)  Trend  2021-2026
                12.4.2  Global  Eculizumab  Gross  Profit  Trend  2021-2026
13  Conclusion


List of Tables and Figures

Figure Product Picture of Eculizumab
Table Product Specifications of Eculizumab
Table Manufacturers List in the Report
Table Manufacturers Production Market Share (%) 2014-2020
Table Regions Overview in 2020
Table Product Type and Standard
Table Type Overview in 2020
Table Product Application and Standard
Table Application Overview in 2020
Figure Industry Chain Structure of Eculizumab
Table Industry News List of Eculizumab
Table Key Challenges
Table Global Eculizumab Sales (K Units) by Types
Figure Global Eculizumab Sales Market Share (%) by Types in 2014
Figure Global Eculizumab Sales Market Share (%) by Types in 2020
Table Plasma Exchange Sales (K Units) and Growth Rate
Figure Plasma Exchange Sales (K Units) and Growth Rate
Table Plasma Infusion Sales (K Units) and Growth Rate
Figure Plasma Infusion Sales (K Units) and Growth Rate
Table Global Eculizumab Revenue (M USD) by Types
Figure Global Eculizumab Revenue Market Share (%) by Types in 2014
Figure Global Eculizumab Revenue Market Share (%) by Types in 2020
Table Plasma Exchange Revenue (M USD) and Growth Rate
Figure Plasma Exchange Revenue (M USD) and Growth Rate
Table Plasma Infusion Revenue (M USD) and Growth Rate
Figure Plasma Infusion Revenue (M USD) and Growth Rate
Table Global Eculizumab Sales (K Units) by Application 2014-2020
Figure Global Eculizumab Sales Market Share (%) by Application in 2014
Figure Global Eculizumab Sales Market Share (%) by Application in 2020
Table PNH Sales (K Units) and Growth Rate 2014-2020
Figure PNH Sales (K Units) and Growth Rate 2014-2020
Table aHUS Sales (K Units) and Growth Rate 2014-2020
Figure aHUS Sales (K Units) and Growth Rate 2014-2020
Table Other Sales (K Units) and Growth Rate 2014-2020
Figure Other Sales (K Units) and Growth Rate 2014-2020
Table Alexion Profiles
Table Alexion Product Information
Table Alexion Eculizumab Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Alexion Eculizumab Sales Change 2014-2020
Table Alexion Eculizumab Market Status Change 2014-2020
Table Global Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table Global Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure Global Eculizumab Sales Market Share (%) in 2014
Figure Global Eculizumab Sales Market Share (%) in 2020
Table Global Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table Global Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure Global Eculizumab Revenue Market Share (%) in 2014
Figure Global Eculizumab Revenue Market Share (%) in 2020
Table Global Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure Global Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure Global Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table Global Eculizumab Gross Margin of Manufacturers 2014-2020
Figure Global Eculizumab Gross Margin of Manufacturers in 2014
Figure Global Eculizumab Gross Margin in 2020
Figure Global Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table USA Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table USA Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure USA Eculizumab Sales Market Share (%) in 2014
Figure USA Eculizumab Sales Market Share (%) in 2020
Table USA Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table USA Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure USA Eculizumab Revenue Market Share (%) in 2014
Figure USA Eculizumab Revenue Market Share (%) in 2020
Table USA Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure USA Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure USA Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table USA Eculizumab Gross Margin of Manufacturers 2014-2020
Figure USA Eculizumab Gross Margin of Manufacturers in 2014
Figure USA Eculizumab Gross Margin in 2020
Figure USA Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Europe Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table Europe Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure Europe Eculizumab Sales Market Share (%) in 2014
Figure Europe Eculizumab Sales Market Share (%) in 2020
Table Europe Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table Europe Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure Europe Eculizumab Revenue Market Share (%) in 2014
Figure Europe Eculizumab Revenue Market Share (%) in 2020
Table Europe Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure Europe Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure Europe Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table Europe Eculizumab Gross Margin of Manufacturers 2014-2020
Figure Europe Eculizumab Gross Margin of Manufacturers in 2014
Figure Europe Eculizumab Gross Margin in 2020
Figure Europe Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Japan Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table Japan Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure Japan Eculizumab Sales Market Share (%) in 2014
Figure Japan Eculizumab Sales Market Share (%) in 2020
Table Japan Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table Japan Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure Japan Eculizumab Revenue Market Share (%) in 2014
Figure Japan Eculizumab Revenue Market Share (%) in 2020
Table Japan Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure Japan Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure Japan Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table Japan Eculizumab Gross Margin of Manufacturers 2014-2020
Figure Japan Eculizumab Gross Margin of Manufacturers in 2014
Figure Japan Eculizumab Gross Margin in 2020
Figure Japan Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Korea Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table Korea Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure Korea Eculizumab Sales Market Share (%) in 2014
Figure Korea Eculizumab Sales Market Share (%) in 2020
Table Korea Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table Korea Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure Korea Eculizumab Revenue Market Share (%) in 2014
Figure Korea Eculizumab Revenue Market Share (%) in 2020
Table Korea Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure Korea Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure Korea Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table Korea Eculizumab Gross Margin of Manufacturers 2014-2020
Figure Korea Eculizumab Gross Margin of Manufacturers in 2014
Figure Korea Eculizumab Gross Margin in 2020
Figure Korea Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table India Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table India Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure India Eculizumab Sales Market Share (%) in 2014
Figure India Eculizumab Sales Market Share (%) in 2020
Table India Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table India Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure India Eculizumab Revenue Market Share (%) in 2014
Figure India Eculizumab Revenue Market Share (%) in 2020
Table India Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure India Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure India Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table India Eculizumab Gross Margin of Manufacturers 2014-2020
Figure India Eculizumab Gross Margin of Manufacturers in 2014
Figure India Eculizumab Gross Margin in 2020
Figure India Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Southeast Asia Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table Southeast Asia Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure Southeast Asia Eculizumab Sales Market Share (%) in 2014
Figure Southeast Asia Eculizumab Sales Market Share (%) in 2020
Table Southeast Asia Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table Southeast Asia Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure Southeast Asia Eculizumab Revenue Market Share (%) in 2014
Figure Southeast Asia Eculizumab Revenue Market Share (%) in 2020
Table Southeast Asia Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure Southeast Asia Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure Southeast Asia Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table Southeast Asia Eculizumab Gross Margin of Manufacturers 2014-2020
Figure Southeast Asia Eculizumab Gross Margin of Manufacturers in 2014
Figure Southeast Asia Eculizumab Gross Margin in 2020
Figure Southeast Asia Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table South America Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table South America Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure South America Eculizumab Sales Market Share (%) in 2014
Figure South America Eculizumab Sales Market Share (%) in 2020
Table South America Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table South America Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure South America Eculizumab Revenue Market Share (%) in 2014
Figure South America Eculizumab Revenue Market Share (%) in 2020
Table South America Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure South America Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure South America Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table South America Eculizumab Gross Margin of Manufacturers 2014-2020
Figure South America Eculizumab Gross Margin of Manufacturers in 2014
Figure South America Eculizumab Gross Margin in 2020
Figure South America Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Global Eculizumab Sales (K Units) by Regions 2014-2020
Table Global Eculizumab Sales Market Share (%) by Regions 2014-2020
Figure Global Eculizumab Sales Market Share (%) by Regions in 2014
Figure Global Eculizumab Sales Market Share (%) by Regions in 2020
Table Global Eculizumab Revenue (M USD) by Regions 2014-2020
Table Global Eculizumab Revenue Market Share (%) by Regions 2014-2020
Figure Global Eculizumab Revenue Market Share (%) by Regions in 2014
Figure Global Eculizumab Revenue Market Share (%) by Regions in 2020
Table Global Eculizumab Price (USD/Unit) by Regions 2014-2020
Figure Global Eculizumab Price (USD/Unit) by Regions in 2014
Figure Global Eculizumab Price (USD/Unit) by Regions in 2020
Table Global Eculizumab Gross Margin by Regions 2014-2020
Figure Global Eculizumab Gross Margin by Regions in 2014
Figure Global Eculizumab Gross Margin by Regions in 2020
Figure Global Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure Global Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure China Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure China Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure USA Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure USA Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure Europe Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure Europe Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure Japan Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure Japan Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure Korea Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure Korea Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure India Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure India Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure Southeast Asia Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure Southeast Asia Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure South America Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure South AmericaEculizumab Revenue (M USD) and Growth Rate 2014-2020
Table Upstream Source for Manufacturers
Table Manufacture Technology of Eculizumab
Figure Cost Structure of Eculizumab in 2020
Table Global Eculizumab Production (K Units) by Regions 2021-2026
Table Global Eculizumab Production Market Share (%) by Regions 2021-2026
Figure Global Eculizumab Production Market Share (%) by Regions in 2020
Figure Global Eculizumab Production Market Share (%) by Regions in 2024
Table Global Eculizumab Revenue (M USD) by Regions 2021-2026
Table Global Eculizumab Revenue Market Share (%) by Regions 2021-2026
Figure Global Eculizumab Revenue Market Share (%) by Regions in 2020
Figure Global Eculizumab Revenue Market Share (%) by Regions in 2024
Figure Global Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure Global Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure China Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure China Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure USA Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure USA Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure Europe Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure Europe Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure Japan Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure Japan Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure Korea Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure Korea Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure India Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure India Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure Southeast Asia Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure Southeast Asia Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure South America Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure South America Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Table Global Eculizumab Production (K Units) by Types 2021-2026
Figure Global Eculizumab Production Market Share (%) by Types in 2020
Figure Global Eculizumab Production Market Share (%) by Types in 2024
Table Plasma Exchange Production (K Units) and Growth Rate
Table Plasma Exchange Revenue (M USD) and Growth Rate
Table Plasma Infusion Production (K Units) and Growth Rate
Table Plasma Infusion Revenue (M USD) and Growth Rate
Table Global Eculizumab Sales Forecast by Application 2021-2026
Figure Global Eculizumab Sales Market Share (%) by Application in 2020
Figure Global Eculizumab Sales Market Share (%) by Application in 2025
Figure PNH Sales and Growth Rate 2021-2026
Figure aHUS Sales and Growth Rate 2021-2026
Figure Other Sales and Growth Rate 2021-2026
Figure Global Eculizumab Price (USD/Unit) Trend 2021-2026
Figure Global Eculizumab Gross Profit Trend 2021-2026










































































 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT